Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | MME | P08473 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30543983 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| SCHEMBL2722882 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| SCHEMBL2722888 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| SCHEMBL1019805 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| SCHEMBL1019806 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL235249 | 0.96 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL29401942 | 0.96 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL6044006 | 0.96 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL235250 | 0.96 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL13737576 | 0.96 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2271368-B1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS SINAI MEDICAL CENTER (US) | 2018-12-05 | — | — | EP | claimed |
| US-8795648-B2 | Poly(beta malic acid) with pendant Leu-Leu-Leu tripeptide for effective cytoplasmic drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2014-08-05 | — | — | US | claimed |
| US-20130084261-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2013-04-04 | — | — | US | claimed |
| US-8309614-B2 | Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2012-11-13 | — | — | US | claimed |
| US-20110020371-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2011-01-27 | — | — | US | claimed |
| EP-2271368-B1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS SINAI MEDICAL CENTER (US) | 2018-12-05 | — | — | EP | disclosed |
| US-8795648-B2 | Poly(beta malic acid) with pendant Leu-Leu-Leu tripeptide for effective cytoplasmic drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2014-08-05 | — | — | US | disclosed |
| US-8795648-B2 | Poly(beta malic acid) with pendant Leu-Leu-Leu tripeptide for effective cytoplasmic drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2014-08-05 | — | — | US | disclosed |
| US-20130084261-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2013-04-04 | — | — | US | disclosed |
| US-20130084261-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2013-04-04 | — | — | US | disclosed |
| US-8309614-B2 | Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309614-B2 | Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery | CEDARS-SINAI MEDICAL CENTER (US) | 2012-11-13 | — | — | US | disclosed |
| US-20110020371-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2011-01-27 | — | — | US | disclosed |
| US-20110020371-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2011-01-27 | — | — | US | disclosed |
| EP-2271368-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | Cedars-Sinai Medical Center (US) | 2011-01-12 | — | — | EP | disclosed |
| EP-2271368-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | Cedars-Sinai Medical Center (US) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009126913-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009126913-A1 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY | CEDARS-SINAI MEDICAL CENTER (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-0022028-B1 | METHOD TO DETECT AND TO ANALYSE GASES, IN PARTICULAR TO PREVENT FIRE | COMPAGNIE CENTRALE SICLI (Société Anonyme) (FR) | 1984-04-18 | — | — | EP | disclosed |
| EP-0022028-A1 | Method to detect and to analyse gases, in particular to prevent fire | COMPAGNIE CENTRALE SICLI (Société Anonyme) (FR) | 1981-01-07 | — | — | EP | disclosed |